SEDABARB

This brand name is authorized in South Africa

Active ingredients

The drug SEDABARB contains one active pharmaceutical ingredient (API):

1 Phenobarbital UNII YQE403BP4D - PHENOBARBITAL

Phenobarbital has sedative effects and has some protective action against all varieties of human partial and generalised epilepsy, with the exception of absence seizures. Phenobarbital is also effective in preventing seizures in the corresponding experimental animal models of epilepsy. Read about Phenobarbital

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SEDABARB Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AA02	Phenobarbital	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives
Discover more medicines within N03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): E/2.3/107